← Evidence map

ArticleBlood advances2023

Dabrafenib, alone or in combination with trametinib, in BRAF V600-mutated pediatric Langerhans cell histiocytosis.

James A Whitlock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

43 papers cite it

2023
2024
2025
2026
this papertrialcites it

5 trials

Full record →Abstract, authors, funding and every citing paper · PMID 36884302